Network News

Ladenburg, Germany, 26 August 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that the China National Medical Products Administration (NMPA) has granted Clinical Trial Approval for a Phase Ib/II clinical trial evaluating pamlectabart tismanitin (HDP-101), the Company’s novel BCMA-targeting ADC, in combination therapy for the […]

Heidelberg-based biotech company REVIER Therapeutics has officially launched. The company, which emerged from research conducted at the German Centre for Cardiovascular Research (DZHK) and Heidelberg University, is developing a novel therapeutic approach for cardiometabolic diseases. REVIER has raised €6 million in seed funding to advance its development programs. At the heart of REVIER’s approach are […]

The European research project THEODORA is launching during “Gold September”, the international childhood cancer awareness month. Researchers at the Heidelberg Medical Faculty of Heidelberg University, drawing on their expertise in clinical research and precision oncology at Hopp Children’s Cancer Center Heidelberg (KiTZ), are collaborating with Institut Curie in Paris, Prinses Máxima Centrum in Utrecht, and […]

Ruperto Carola in 59th place worldwide – among the “Top 3” in Germany Heidelberg University has achieved top placements in the 2026 Academic Ranking of World Universities. As in the previous year, it is one of the “Top 3” universities in Germany. In the global comparison, Ruperto Carola is in 59th position in this so-called […]

As part of the 23rd annual global charity run, the “Roche Children’s Walk,” numerous Roche employees throughout Germany participated in a variety of running, sports, and recreational activities. At the Grenzach-Wyhlen, Mannheim, Penzberg, and Ludwigsburg sites, a total of 53,875 euros was raised. With the German Roche companies matching this amount for global aid projects, […]

CHICAGO – August 18, 2026 – VectorBuilder, a global leader in gene delivery technologies, and Lir Therapeutics, a company pushing the boundaries of vector engineering with AI, today announced a strategic collaboration to develop adeno-associated virus (AAV) capsids designed not only for strong biological performance, but also for the manufacturability and scalability required to bring gene […]

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

Basel, Switzerland / Köln, Germany August 12, 2026 The University Hospital Cologne (Universitätsklinikum Köln, UHC) has chosen the Celonic Group as its CDMO partner for advanced process development and GMP manufacturing of its monoclonal antibody targeting Pseudomonas aeruginosa, a Gram‑negative pathogen responsible for severe hospital‑acquired infections, biofilm‑driven persistence, and rising antimicrobial resistance. The antibody program is […]